TC Medical(SH:600763) Sou Hu Cai Jing·2025-09-09 12:15Core Viewpoint - Tongce Medical (600763) experienced a decline in stock price, closing at 47.12 yuan on September 9, 2025, with a drop of 1.36% [1] Financial Performance - For the first half of 2025, Tongce Medical reported a main revenue of 1.448 billion yuan, an increase of 2.68% year-on-year [3] - The net profit attributable to shareholders was 321 million yuan, up 3.67% year-on-year [3] - The second quarter of 2025 saw a single-quarter main revenue of 704 million yuan, a slight increase of 0.24% year-on-year [3] - The company’s gross profit margin stood at 40.75%, while the net profit margin was 26.26% [3] Market Activity - On September 9, 2025, the net outflow of main funds was 36.31 million yuan, accounting for 8.84% of the total transaction amount [1] - Retail investors showed a net inflow of 27.30 million yuan, representing 6.65% of the total transaction amount [1] - Over the past five days, the stock has seen fluctuating fund flows, with notable net inflows and outflows from different investor categories [2] Industry Comparison - Tongce Medical's total market value is 21.076 billion yuan, slightly above the industry average of 20.997 billion yuan [3] - The company ranks 5th in the industry based on price-to-earnings ratio (32.81) and 3rd based on net profit margin (26.26%) [3] - The company has a debt ratio of 27.51% and reported investment income of 27.09 million yuan [3] Analyst Ratings - In the last 90 days, 7 institutions rated the stock, with 5 buy ratings and 2 hold ratings [4] - The average target price set by institutions over the past 90 days is 50.19 yuan [4]